Purchase Order 75D30124P20181

Award Date 9/17/24
Potential Completion Date 10/9/24
Potential Value $95K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Plain City, OH 43064, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a firm-fixed-price purchase order to Altona Diagnostics USA Inc., a foreign-owned, for-profit organization, for the delivery of MPOX (monkeypox) detection kits. The contract, which does not have a set-aside designation, is valued at $59,938.76 and has a completion date of April 19, 2024. Altona Diagnostics USA Inc. is a company that develops and manufactures in vitro...
The Centers for Disease Control and Prevention awarded a $32,037 purchase order to Life Technologies Corporation for MPOX surveillance samples. As the prime contractor, Life Technologies will provide laboratory supplies and materials to support CDC's ongoing efforts to monitor and track cases of the monkeypox virus. The contract was awarded under a firm fixed price arrangement and will be performed in Baltimore, Maryland over a two month period concluding in late October 2023. Thermo Electron...
This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $174,160.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostic testing products, for the provision of CBOT singleplex assays and related laboratory supplies. This contract does not have a set-aside designation. XCR Diagnostics, Inc. is a subsidiary of Fluoresentric, Inc., another manufacturer of goods. The contract, awarded out of the CDC's...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...
XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors...
This is a $15,655.00 firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Miscellaneous Foreign Awardees, a for-profit foreign organization registered to do business with the U.S. government. The contract is for lab services and does not have a set-aside designation. The contract has an ultimate completion date of July 9, 2024. Miscellaneous Foreign Awardees has experience providing a range of goods and services to U.S. government agencies...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Eppendorf North America, Inc., a foreign-owned for-profit organization that specializes in providing laboratory equipment, consumables, and services to the U.S. government. The $4,970.54 firm-fixed-price purchase order is for the delivery of unspecified laboratory equipment to the CDC's Pittsburgh location, with a completion date of June 30, 2020. The contract does not have a set-aside...
This federal contract award is for LAB SERVICES provided by Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The firm fixed-price purchase order is valued at $134,673.00 and has an ultimate completion date of September 27, 2028. The contract does not utilize any set-aside designations. The award appears to be part of Abbott Molecular's broader federal contract portfolio, which includes multiple Indefinite...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call placed against the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract by the Centers for Disease Control and Prevention (CDC) for data subscription, project management, and consulting services to support the agency's response to the monkeypox outbreak. The award, with a ceiling value of $67,590.76, has a period of performance through September 29, 2023. The prime contractor is Porter Novelli Public...

This is a federal contract award to Altona Diagnostics USA Inc., a foreign-owned, for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, a civilian agency. The contract is for the delivery of MPOX (monkeypox) detection kits, with a ceiling value of $94,926.42. The contract is structured as a firm fixed-price purchase order, without any set-aside designation. This award is the latest in a series of contracts between Altona Diagnostics USA Inc. and the CDC Pittsburgh, demonstrating the company's role as a supplier of specialized diagnostic tools for infectious disease monitoring and response. The recurring nature of these awards underscores Altona Diagnostics USA Inc.'s importance in supporting the CDC's efforts to address both established and emerging public health threats.

Generated 10/16/24, 9:06 AM